<DOC>
	<DOC>NCT01533506</DOC>
	<brief_summary>The patient has failed all other available agents and has intractable epilepsy due to Dravet Syndrome. Stiripentol is highly efficacious in Dravet Syndrome. The overall goals of therapy with Stiripentol are primarily to significantly reduce the frequency and severity of seizures.</brief_summary>
	<brief_title>Stiripentol in Dravet Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Epilepsies, Myoclonic</mesh_term>
	<mesh_term>Stiripentol</mesh_term>
	<criteria>Genetic diagnosis of Dravet syndrome with intractable seizures despite failing all available medications for seizures</criteria>
	<gender>Female</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>treatment with stiripentol</keyword>
</DOC>